异柠檬酸脱氢酶
胶质瘤
分割
计算机科学
人工智能
任务(项目管理)
图像分割
模式识别(心理学)
医学
生物化学
化学
管理
癌症研究
经济
酶
作者
Xiaoyu Shi,Yinhao Li,Jingliang Cheng,Jie Bai,Guohua Zhao,Yen‐Wei Chen
标识
DOI:10.1109/embc40787.2023.10340355
摘要
According to the 2021 World Health Organization IDH status prediction scheme for gliomas, isocitrate dehydrogenase (IDH) is a particularly important basis for glioma diagnosis. In general, 3D multimodal brain MRI is an effective diagnostic tool. However, only using brain MRI data is difficult for experienced doctors to predict the IDH status. Surgery is necessary to be performed for confirming the IDH. Previous studies have shown that brain MRI images of glioma areas contain a lot of useful information for diagnosis. These studies usually need to mark the glioma area in advance to complete the prediction of IDH status, which takes a long time and has high computational cost. The tumor segmentation task model can automatically segment and locate the tumor region, which is exactly the information needed for the IDH prediction task. In this study, we proposed a multi-task deep learning model using 3D multimodal brain MRI images to achieve glioma segmentation and IDH status prediction simultaneously, which improved the accuracy of both tasks effectively. Firstly, we used a segmentation model to segment the tumor region. Also, the whole MRI image and the segmented glioma region features as the global and local features were used to predict IDH status. The effectiveness of the proposed method was validated via a public glioma dataset from the BraTS2020. Our experimental results show that our proposed method outperformed state-of-the-art methods with a prediction accuracy of 88.5% and average dice of 79.8%. The improvements in prediction and segmentation are 3% and 1% compared with the state-of-the-art method, respectively.
科研通智能强力驱动
Strongly Powered by AbleSci AI